Trial NCT04671017; ISRCTN 82411169
Publication Lazarus R, J Infect, 2022
Primary outcome on the report: 1. Frequency and severity of solicited adverse events (AE) within 7 days of first or second vaccination; 2. Geometric mean titres (GMT) for SARS-CoV-2 neutralising antibodies at day 36

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.